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Development of fluoroquinolone resistance can involve several mechanisms that include
chromosomal mutations in genes (gyrAB and parCE) encoding the target bacterial
topoisomerase enzymes, increased expression of the AcrAB-TolC efflux system, and
acquisition of transmissible quinolone-resistance genes. In this study, 176 Salmonella
isolates from animals with a broad range of ciprofloxacin MICs were collected to analyze
the contribution of these different mechanisms to different phenotypes. All isolates
were classified according to their ciprofloxacin susceptibility pattern into five groups as
follows: highly resistant (HR), resistant (R), intermediate (I), reduced susceptibility (RS),
and susceptible (S). We found that the ParC T57S substitution was common in strains
exhibiting lowest MICs of ciprofloxacin while increased MICs depended on the type of
GyrA mutation. The ParC T57S substitution appeared to incur little cost to bacterial
fitness on its own. The presence of PMQR genes represented an route for resistance
development in the absence of target-site mutations. Switching of the plasmid-mediated
quinolone resistance (PMQR) gene location from a plasmid to the chromosome was
observed and resulted in decreased ciprofloxacin susceptibility; this also correlated with
increased fitness and a stable resistance phenotype. The overexpression of AcrAB-
TolC played an important role in isolates with small decreases in susceptibility and
expression was upregulated by MarA more often than by RamA. This study increases
our understanding of the relative importance of several resistance mechanisms in the
development of fluoroquinolone resistance in Salmonella from the food chain.
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INTRODUCTION
Salmonella species are important foodborne pathogens and associated infections can be life-
threatening, particularly in elderly and immunocompromised patients (Majowicz et al., 2010).
Fluoroquinolones (FQ) are the primary treatment option for life-threatening Salmonella infections
in clinical practice (Hohmann, 2001). However, the emergence of FQ resistance in Salmonella
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spp. has limited therapeutic options and the World Health
Organization categorized FQ-resistant Salmonella as a high
priority pathogen for the research and development of new
antibiotics in 2017 (WHO, 2017).
Mechanisms of FQ resistance include chromosomal mutations
in the target enzymes, DNA gyrase and topoisomerase IV,
down-regulation of outer membrane porin expression coupled
with increases in active drug efflux, as well as acquisition of
transmissible quinolone-resistance genes. The development of
FQ resistance is often mediated by the accumulation of multiple
mutations in a stepwise process and the interplay between
multiple resistance mechanisms can result in the development
of highly resistant mutants (Redgrave et al., 2014; Hooper
and Jacoby, 2015). It has been suggested that, mutation of
chromosomally located primary target genes represents the first
step in the development of quinolone resistance. For Gram-
negative organisms such as Escherichia coli, the primary target
is typically the GyrA subunit of gyrase. The most common
mutation site in the quinolone resistance determining region
(QRDR) is serine 83 of GyrA. Highly resistant organisms
typically carry a combination of mutations within gyrA and
parC (Machuca et al., 2014; Redgrave et al., 2014; Hooper
and Jacoby, 2015). However, whilst similar mutations are often
recovered in Salmonella spp. as in E. coli after quinolone exposure
(Marcusson et al., 2009; Machuca et al., 2014), the phenotypic
impact resulting from target site mutations seem to have a smaller
impact (conferring smaller MIC increases) than in E. coli (Heisig,
1996; Lin et al., 2015).
The chromosomal multidrug efflux pump AcrAB-TolC is
capable of actively removing FQs and other drugs from the
bacterial cell and is known to play an important role in
the development of high level FQ resistance (Redgrave et al.,
2014),overexpression of acrAB has been suggested to be a first
step that facilitates high-level resistance development following
acquisition of target site mutations (Giraud et al., 2000;
Singh et al., 2012).
Transmissible quinolone-resistance mechanisms are often
plasmid associated and so are known as “plasmid-mediated
quinolone resistance” (PMQR) determinants. These typically
confer a low-level of decreased susceptibility to quinolones.
As with efflux over-expression, carriage of PMQRs can also
facilitate the selection of mutants with higher levels of
quinolone resistance through additional chromosomally encoded
mechanisms (Hooper and Jacoby, 2015).
There is evidence for clinical quinolone resistance to emerge
without target site mutation, a fully resistant E. coli strain
with a ciprofloxacin MIC of 4 mg/L but without topoisomerase
mutations has been reported and was shown to harbor plasmid-
mediated qnrS1 and oqxAB, as well as overexpressing acrAB
and genes encoding for other efflux pumps (Sato et al., 2013).
Similarly, an experimentally derived mutant carrying five plasmid
copies of qnrA1 elevated the ciprofloxacin MIC from 0.25
to 2 mg/L; this MIC value exceeds the CLSI breakpoint for
resistance (Vinue et al., 2019). In a separate study, several PMQR
genes either alone or in combination were reported to mediate
ciprofloxacin resistance development in Salmonella isolates that
did not contain target gene mutations (Lin et al., 2015).
The acquisition of antibiotic resistance in bacteria via either
chromosomal or plasmid mechanisms is often accompanied by a
fitness cost. But this is not always the case in quinolone resistance
development. A study (Marcusson et al., 2009) investigating the
fitness effect of various QRDR mutations and efflux activity in
E. coli revealed that GyrA 83 mutations conferred a fitness gain
on the isolates while GyrA 87 substitutions were associated with
fitness costs. Acquisition of a triplet of GyrA 83, GyrA 87, and
ParC 80 substitutions resulted in fitness gain when efflux was not
involved. De-repressed efflux activity was, however, associated
with fitness costs. Resistant mutants harboring the same triplet
mutations, which was obtained by exposure of a quinolone-
susceptible SalmonellaTyphimurium clinical isolate to increasing
concentrations of ciprofloxacin also showed a diminished ability
to grow (Fabrega et al., 2014). Huseby et al. (2017) demonstrated
that the even low-levels of ciprofloxacin strongly favor growth
of topoisomerase mutants and even genotypes (gyrA 83 and
parC 80) which carry a cost in drug free media are favored in
sub-inhibitory concentrations of quinolone.
Most of our understanding of the contributions and fitness
costs of different mechanisms to quinolone resistance is from
laboratory studies or analysis of small numbers of mutants.
Given the importance of quinolone resistance as a phenotype,
a thorough understanding of the impact of the different FQ
resistance mechanisms in the real world is of crucial importance.
In the present study, 176 Salmonella isolates with a broad range
of ciprofloxacin MIC distributions were collected. These isolates
were analyzed for correlations between ciprofloxacin resistance
phenotypes and: target site mutations, expression levels of acrAB,
and prevalence of PMQR genes. This research assessed the
relative contributions of defined mutant combinations toward
fitness in different FQ concentrations and informs how FQ
resistance evolves in the food chain.
MATERIALS AND METHODS
Bacterial Strains and Susceptibility
Testing
Salmonella isolates (126) used in this study were isolated from
pork samples in a large-scale slaughterhouse between 2013 and
2014 (Yang et al., 2017). The ciprofloxacin MICs ranged from
<0.015 to 64 mg/L although none of these isolates were inhibited
by ciprofloxacin concentrations between 0.125 and 2 mg/L. In
order to generate a consecutive ciprofloxacin MIC distribution
range for each MIC value, we selected 50 additional strains from
food-producing animals and raw meat (chicken and pork) as
described elsewhere (Zhang et al., 2016; Zhang C.Z. et al., 2019;
Yang et al., 2017). This included 11 isolates from swine, 9 from
chickens, 17 from ducks and 13 from meat samples (10 chicken
and 3 pork) (Table 1). Although efforts were made to screen for
strains with a ciprofloxacin MIC between 0.25 and 2 mg/L, these
strains were rare. We only identified 3, 3, and 4 isolates in the
entire strain collection that possessed ciprofloxacin MICs of 0.5,
1, and 2 mg/L, respectively.
The majority of the strains isolated from pork samples
were serovars Derby, Rissen and Indiana as previously
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TABLE 1 | Sources and ciprofloxacin MIC values for Salmonella isolates used in this study.
Sample origin Sampling year No. of isolates possessing the indicated ciprofloxacin MIC (mg/L) Total
≤0.015 0.03 0.06 0.125 0.25 0.5 1 2 4 8 16 32 64
Pork 2013–2014 28 5 47 0 0 0 0 0 4 29 0 9 4 126
Pork 2016 1 0 0 1 1 0 0 0 0 0 0 0 0 3
Chicken meat 2015 4 1 0 1 0 0 0 0 1 0 0 0 0 10
Swine 2014, 2016 1 1 0 2 1 0 3 4 1 0 0 0 0 11
Chicken 2014, 2016 0 0 0 4 3 0 1 0 0 0 0 2 0 9
Duck 2016 3 0 0 2 0 3 0 0 1 7 1 0 0 17
Total 37 7 47 10 5 3 3 4 7 36 1 11 4 176
described (Yang et al., 2017). The 50 additional isolates
included Typhimurium (15), Indiana (12), Enteritidis (7),
Derby (5), and 11 others.
Salmonella enterica subsp. enterica serovar Typhimurium
SL1344 (MICCIP = 0.015 mg/L) was kindly provided by Prof.
Laura Piddock (Institute of Microbiology and Infection,
University of Birmingham) and used as a standard reference
strain in this study. The MICs of ciprofloxacin were determined
by the agar dilution method following CLSI guidelines
(CLSI, 2019).
Detection of Target Gene Mutations and
the Presence of PMQR Genes
Identification of mutations in the quinolone resistance
determining regions (QRDR) of gyrA, gyrB, parC, and parE
and identification of qnr, aac(6′)-Ib-cr, qepA and oqxABR genes
were performed using PCR amplification, primers used are
listed in Supplementary Table 1. All PCR amplicons were
sequenced by the BGI (Shenzhen, China), and the wild-type
Salmonella Typhimurium LT2 strain was used as a comparison
to identify mutations.
Detection of the oqxABR Circular
Intermediates
All oqxABR-positive Salmonella isolates were screened for the
presence of the IS26 insertion sequence (IS), and cyclization
of the IS26-oqxABR region was determined using primers oqx-
IF and oqx-IR. Sequence identity of all PCR amplicons was
confirmed by DNA sequence analysis.
Location of PMQR Genes
The location of PMQR genes and the sizes of PMQR gene-
positive plasmids were estimated by S1-PFGE and/or I-CeuI-
PFGE followed by Southern blot hybridization with digoxigenin-
dUTP labeled probes of oqxAB, qnrS, and/or 23S rDNA genes.
Primers used are listed in Supplementary Table 1. Briefly,
agarose-embedded DNA for each Salmonella strain was digested
with 1 U S1 nuclease (Takara Biotechnology, Dalian, China) at
37◦C for 45 min or I-CeuI (NEB, Ipswich, MA, United States) for
3 h. The restriction fragments were separated by electrophoresis
in 0.5 × Tris-borate-EDTA buffer at 14◦C for 19 h with pulse
times of 2.2 to 54.2 s using a CHEF-MAPPER System (Bio-Rad
Laboratories, Hercules, CA, United States). Agarose-embedded
DNA from strain H9812 that had been in situ digested with
XbaI (Takara Biotechnology, Dalian, China) at 37◦C for 3 h was
used as a DNA size marker. The gel was stained with ethidium
bromide and DNA bands were visualized under UV light. DNA
was transferred to a Hybond-N + membrane for Southern
hybridization using conditions suggested by the manufacturer
(GE Healthcare, Little Chalfont, United Kingdom). Blots were
probed with PMQR genes containing digoxigenin labels using
a commercial DIG High Prime DNA Labeling and Detection
Starter Kit I (Roche Applied Science, Mannheim, Germany).
Gene Expression Analysis by qRT-PCR
Bacterial strains were grown in minimal media to an OD600 nm
of 0.6 and total RNA was isolated using the RNAiso Plus Kit
(Takara); mRNAs were reverse transcribed using PrimeScript RT
with gDNA Eraser (Takara). The cDNA was quantified using
an iQ5 multicolor real-time PCR system (Bio-Rad) using gene-
specific primers (Supplementary Table 1), and an iQ SYBR
Green Supermix (Bio-Rad). The 16S rRNA gene was used as
an internal control gene and relative expression levels of each
gene were calculated using the 11Ct method and the software
provided with the instrument. Data are presented as mean ± SD
from three independent assays, in which each RNA sample was
tested in triplicate.
Competitive Fitness Measurements
To directly measure fitness impacts of different resistance
mutations we used competition assays between pairs of
strains selected to carry different combinations of resistance
mechanisms, and with different susceptibility levels to
ciprofloxacin. The selected pairs competed against each
other were; S(−)/RS(−), RS(c +)/I(p +), I(p +)/R(c +),
and I(p +)/HR(p +). In addition, to eradicate any possible
strain and serovar specific bias, competition assays were also
completed between selected serovar Indiana strains with different
resistance mechanisms, RS(−)/HR(p +) (strains HB137/K46)
and I(p+)/HR(p+) (strains SP80/K46, and SP80/CL108).
Fitness was analyzed as previously described with some
modifications (Zhang C.Z. et al., 2017). Growth competition was
determined by pyrosequencing the single nucleotide variations in
ParC which distinguished each pair of competed strains. Briefly,
the competitive paired strains were mix and co-cultured (1:1
ratio) in antibiotic-free LB broth for 18 h and DNA was extracted
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FIGURE 1 | Ciprofloxacin MIC distributions in 176 Salmonella strains used in this study.
using a standard phenol-chloroform-heat method. The DNA
from the competitive growth assays was amplified by PCR in
triplicate using biotinylated primer pairs targeting the region
containing the single nucleotide polymorphism to distinguish
the two organisms in the assay by mutations in ParC. All
PCR amplifications were visualized on 1% agarose gels prior to
pyrosequencing. The purified PCR products were pyrosequenced
at BGI. Competition coefficients were defined as the ratio of
the strain pairs subjected to different incubation conditions and
calculated by measuring percentage yield of the single nucleotide
mutations in parC. A competition coefficient <1 indicated that
the less susceptible strain was more abundant after competition.
RESULTS
Assembly and Definition of Study Panel
of Isolates
A primary aim of our study was to identify Salmonella isolates
with a broad range of ciprofloxacin MICs. We selected 176
Salmonella strains from 1,280 isolates, amongst which 91 were
susceptible to ciprofloxacin, 20 were deemed intermediate and
65 were resistant according to CLSI breakpoints. However,
epidemiologically there were clearly more than three levels
of susceptibility in the populations, likely to reflect distinct
combinations of resistance mechanisms. Therefore, we
applied a 5-level interpretation system using “epidemiological
breakpoints.” This system relies on overlapping normal
distributions of MIC values (Kronvall, 2010; Zayed et al., 2015).
The resulting categories were designated as: highly resistant
(HR), resistant (R), intermediate (I), reduced susceptibility (RS),
and susceptible (S) (Figure 1). We then randomly selected a total
of 32 strains, 5∼7 strains from each group, for detailed study of
gene expression and carriage of specific mutations (Table 2 and
Supplementary Figure 1).
Correlation of QRDR Target Gene
Mutations With MIC Category
Among the isolates that were analyzed, none contained QRDR
mutations in gyrB and parE. In contrast, parC mutations that
resulted in the ParC T57S substitution were present in S and
RS strains with an MICCIP of 0.06 mg/L. ParC T57S was not
seen in RS strains when the MICCIP increased to 0.25 and
0.5 mg/L. Isolates with these MICs carried single GyrA S83Y
or D87Y substitutions. The “I” strains tested only possessed
GyrA D87N single substitutions; interestingly, the ParC T57S
substitution was again seen in some R strains, but these lacked
GyrA mutations (although had other mechanisms as outlined
below). The HR strains all possessed multiple substitutions in
both GyrA (S83F/D87G) and ParC (T57S/S80R) (Table 2). The
identification of these mutations was positively correlated with
their assignment into the 5-level interpretation system.
The Presence and Location of PMQR
Genes
Reduced susceptibility strains (ParC T57S) that possessed MICCIP
values of 0.06 mg/L also harbored chromosomal copies of
oqxABR. PMQR genes were not present in the RS strains that
contained the single GyrA substitutions S83Y or D87Y. When
the MICCIP levels reached 1–2 mg/L (I strains), the presence
of plasmid-borne copies of both oqxAB and aac(6′)-Ib-cr were
detected on ∼180-kb plasmids. In the R strains, oqxAB, aac(6′)-
Ib-cr and qnrS were detected and all were located on the





















TABLE 2 | Characteristics of Salmonella enterica isolates from food-producing animals in China.
Groups Strains Serotype MICCIP (mg/L) QRDR Mutationsa mRNA (± SD)c PMQR genesb
gyrA parC acrA acrB tolC ramA marA soxS oqxAB aac (6′)-Ib-cr qnrS
S M61 Rissen 0.008 – T57S 10.40 (9.08) 6.61(6.35) 1.32(0.43) 0.47(0.39) 2.5(2.06) 6.71(10.44) – –
M36 Rissen 0.008 – T57S 3.96 (3.90) 2.55(2.97) 8.14(8.46) 0.23(0.16) 1.65(1.44) 10.78(17.81) – –
JH51 NT 0.008 – T57S 8.72 (9.76) 7.64(9.11) 25.44(23.33) 0.63(0.44) 2.62(3.2) 25.28(42.22) – –
JH196 NT 0.008 – T57S 6.72 (5.90) 5.29(7.57) 8.55(9.17) 0.72(0.83) 0.97(0.89) 6.86(10.89) – –
R17 Rissen 0.008 – T57S 4.58 (3.13) 5.83(3.73) 0.54(0.36) 0.36(0.33) 4.23(5.46) 1.88(2.03) – –
A35 Rissen 0.015 – T57S 10.26 (9.82) 11.84(10.36) 1.83(0.66) 0.78(0.7) 6.55(8.7) 8.47(11.12) – –
D71 Derby 0.015 – T57S 40.23 (68.59) 29.72(49.98) 4.69(6.19) 0.88(0.57) 128.1(215.92) 34.74(58.72) – –
RS M39 Derby 0.06 – T57S 7.22 (11.53) 6.99(10.2) 25.26(27.39) 0.52(0.43) 44.88(67.58) 14.31(23.17) C + –
A42 Rissen 0.06 – T57S 14.41 (23.84) 12.77(19.28) 61.16(80.08) 0.61(0.49) 74.2(110.15) 27.34(44.57) C + –
J24 Derby 0.06 – T57S 16.96 (28.80) 14.33(23.41) 63.41(85.18) 0.64(0.57) 81.66(125.27) 28.23(45.73) C + –
HB137 Indiana 0.25 D87Y – 14.70 (24.60) 18.79(30.34) 77.49(104.2) 1.66(1.43) 75.06(106.06) 31.07(50.41) – –
3 Typhimurium 0.5 S83Y – 15.63 (26.20) 17.39(28.43) 61.87(82.57) 0.88(0.71) 76.44(125.51) 17.07(27.52) – –
4 Typhimurium 0.5 S83Y – 24.12 (41.04) 29.5(50.16) 116.38(159.45) 0.58(0.58) 265.95(441.87) 31.27(52.95) – –
I SP79 Typhimurium 1 D87N – 1.09 (1.55) 0.59(0.74) 0.33(0.44) 0.38(0.56) 0.57(0.78) 0.24(0.24) ∼180kb P + ∼180kb P +
SP128 Typhimurium 1 D87N – 6.12 (8.28) 6.27(9.02) 0.57(0.76) 2.3(3.37) 89.42(78.44) 2.37(1.82) – –
SP80 Indiana 1 D87N – 5.42 (8.42) 6.68(10.81) 6.41(9.94) 0.39(0.27) 20.03(25.57) 1.74(2.32) ∼180kb P + ∼180kb P +
SP116 Typhimurium 2 D87N – 1.06 (0.79) 5.69(8.64) 5.6(8.27) 0.32(0.22) 6.71(6.85) 1.33(1.71) ∼180kb P + ∼180kb P +
SP124 Typhimurium 2 D87N – 0.93 (1.14) 0.7(0.82) 1.28(1.53) 0.36(0.52) 0.61(0.65) 0.23(0.19) ∼180kb P + ∼180kb P +
R E39 Derby 4 – T57S 0.73 (1.03) 0.51(0.59) 1.67(2.14) 0.43(0.65) 0.64(0.62) 0.35(0.29) C + C + C +
E16 Derby 4 – T57S 1.03 (1.68) 0.34(0.41) 0.59(0.56) 0.44(0.69) 0.31(0.42) 0.15(0.18) C + C + C +
F64 Derby 4 – T57S 0.45 (0.62) 0.32(0.37) 0.58(0.55) 0.54(0.64) 0.77(0.88) 0.24(0.18) C + C + C +
E9 Derby 8 – T57S 0.46 (0.50) 0.3(0.27) 0.54(0.53) 0.47(0.59) 0.5(0.62) 0.19(0.1) C + C + C +
E62 Indiana 8 – T57S 0.68 (1.07) 0.38(0.46) 0.46(0.42) 0.36(0.35) 0.66(0.62) 0.21(0.1) C + C + C +
F92 Derby 8 – T57S 1.05 (1.75) 0.72(1.17) 1.06(0.7) 0.88(0.75) 0.52(0.33) 0.15(0.04) C + C + C +
HR CL108 Indiana 32 S83F, D87G T57S, S80R 0.86 (1.43) 0.45(0.7) 0.04(0.03) 5.71(4.87) 2.11(1.32) 0.34(0.37) C + C + C +
K46 Indiana 32 S83F, D87G T57S, S80R 3.21 (5.51) 1.14(1.88) 0.12(0.1) 2.46(1.95) 3.83(5.11) 0.23(0.1) – ∼240kb P +
E58 Indiana 64 S83F, D87G T57S, S80R 6.18 (10.57) 3.61(6.08) 0.27(0.21) 24.95(26.7) 7.42(11.24) 1.69(2.27) – ∼240kb P +
J20 Indiana 64 S83F, D87G T57S, S80R 2.98 (5.00) 1.04(1.45) 0.11(0.07) 7.62(11.22) 2.33(1.85) 0.31(0.36) C + C + C +
J46 Indiana 64 S83F, D87G T57S, S80R 2.03 (3.25) 1.16(1.45) 0.11(0.07) 10.98(16.91) 3.56(3.23) 1.32(1.24) C + C + C +
E25 Indiana 64 S83F, D87G T57S, S80R 4.88 (7.84) 3.31(3.86) 0.39(0.27) 42.42(46.68) 9.96(9.58) 3.02(2.99) – ∼240kb P +
E54 Indiana 64 S83F, D87G T57S, S80R 60.86 (101.91) 50.91(86.83) 5.75(9.87) 59.04(67.8) 234.43(390.32) 46.22(79.61) – ∼240kb P +
B44 Indiana 64 S83F, D87G T57S, S80R 15.66 (23.54) 8.43(11.93) 0.61(0.77) 18.01(17.75) 44.57(56.69) 1.09(0.99) – ∼240kb P +
−, Wild-type allele (no mutation).
aQRDR, amino-acids substitutions in Quinolone Resistance Determining Region of topoisomerases encoding genes; gyrB and parE in all detected strains are all wild-type allele (no mutation).
bPMQR, Plasmid Mediated Quinolone Resistance; qnrA, B, C, D and qepA genes cannot be detected in all Salmonella isolates; C + : chromosomally located.
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FIGURE 2 | Formation of a circular intermediate by oqxABR operon. (A) Comparison between genetic structure of transposon Tn6010 located in pOLA52
(accession no. NC_010378) and the oqxABR operon positive strains. (B) The circular form of Tn6010 and the approximate locations of the reverse primers oqx-IF
and oqx-IR (line arrows). (C) Gel electrophoresis of PCR amplicons corresponding to the circular intermediate of Tn6010, detectable in oqxABR-positive strains using
the reverse primers oqx-IF and oqx-IR. Primers are listed in Supplementary Table 1. NC, Negative Control.
chromosome. In HR strains, aac(6′)-Ib-cr was found on either
∼240-kb plasmids or was present with oqxAB and qnrS2 on the
chromosome (Table 2).
Expression of AcrAB-TolC and
Regulators
We next analyzed whether increases in efflux pump expression
correlated with the MIC categories of our isolates. The expression
of efflux complex (acrA, acrB, and tolC) and regulatory (ramA,
marA, and soxS) genes for the subset of 32 Salmonella
isolates were measured (Table 2 and Supplementary Figure 2).
Compared with S. Typhimurium SL1344, the RS strains exhibited
higher expression of acrAB-tolC and the regulator marA but not
ramA. Furthermore, the majority of I strains exhibited increased
expression of efflux pump genes with concurrent overexpression
of marA. Surprisingly, the efflux pump genes were not expressed
more in R strains compared with S. Typhimurium SL1344,
whereas there was increased expression of acrA, acrB, ramA, and
marA in HR strains compared with S. Typhimurium SL1344.
A two-way ANOVA test of expression values for the regulator
genes indicated the differences between groups were not likely to
be observed by chance (p 0.007).
oqxABR Circular Intermediates
All 16 oqxABR-positive strains possessed IS26 sequences
flanking the oqxABR operon (Figure 2A). In addition, all
these strains, regardless of whether the genes were located
on a plasmid or chromosome, were positive for the presence
of circular intermediates containing IS26 and the oqxABR
genes (Figures 2B,C). Sequencing of this circular intermediate
confirmed that the length of the intermediate was 6,026 bp and
that oqxABR harbored a complete copy of IS26. This intermediate
structure was like the oqxABR operon present in the widespread
composite transposon Tn6010 found in plasmid pOLA52 from
E. coli (Norman et al., 2008). These results indicate that the
Tn6010 element was unstable and prone to excision in our
Salmonella isolates.
Competitive Fitness
We compared the competitive fitness of closely related pairs
of isolates selected to represent the different combinations of
resistance mechanisms and susceptibility levels observed in
the whole panel. This included the presence of target gene
mutations and presence of PMQR genes on the chromosome
(c+) or on plasmids (p+). The competitive growth experiments
included the pairs S(−)/RS(−), RS(c +)/I(p +), I(p +)/R(c +),
and I(p +)/HR(p +) and Indiana strains RS(−)/HR(p +)
(strain HB137/K46) and I(p +)/HR(p +) (strain SP80/K46, and
SP80/CL108). All strains used in competition assays are shown in
Table 3.
The competition coefficient for the S (−)/RS (−) pair
was 1.13, suggesting that the presence of a substitution of
GyrA D87Y presented a burden to strain HB137 (RS), while
ParC T57S did not impair strain M36 (S). The competition
coefficient for RS(c +)/I(p +) counterparts was 1.53, indicating
that carriage of both GyrA D87N and the two plasmid
Frontiers in Microbiology | www.frontiersin.org 6 May 2021 | Volume 12 | Article 663731
fmicb-12-663731 April 30, 2021 Time: 20:16 # 7
Chang et al. Contribution of Ciprofloxacin Resistance Mechanisms
TABLE 3 | Characteristics of strains used in growth competition assays.
Strain Susceptibility groupa MICCIP (mg/L) Target mutations PMQR genes Gene location
M36 S (−) 0.008 ParC T57S – ND
M39 RS (c +) 0.06 ParC T57S oqxAB, chromosome
HB137 RS (−) 0.25 GyrA D87Y – ND
SP79 I (p +) 1 GyrA D87N oqxAB, aac(6′)-Ib-cr plasmid
SP80 I (p +) 1 GyrA D87N oqxAB, aac(6′)-Ib-cr plasmid
F64 R (c +) 4 ParC T57S oqxAB, aac(6′)-Ib-cr and qnrS chromosome
K46 HR (p +) 32 GyrA, S83F/D87G ParC, T57S/S80R aac(6′)-Ib-cr plasmid
CL108 HR(c +) 32 GyrA, S83F/D87G ParC, T57S/S80R oqxAB, aac(6′)-Ib-cr and qnrS chromosome
a
−, lacking PMQR; +, PMQR present; p, plasmid location; c, chromosomal location; ND, not detected.
PMQR genes produced a burden on strain SP79 (I). The
I(p +)/R(c +) competition yielded a competition coefficient of
0.76, indicating the three chromosomal PMQR genes in strain
F64 (R) produced less of a burden than when these genes
were plasmid-borne. The HR strain K46 carried 2 mutations
in GyrA and 2 in ParC. The presence of the plasmid-borne
PMQR gene aac(6′)-Ib-cr resulted in a competitive disadvantage
when compared with the I strain SP79 that possessed a GyrA
single mutation; this resulted in a competition coefficient of 1.95
for I(p +)/HR(p +) (Figure 3). The same patterns were seen
from the corresponding experiments using identical Indianan
strains [I(p+)/HR(p+)], SP80/K46, and SP80/CL108. However,
RS strain HB137, harboring a substitution of GyrA D87Y and
overexpressing AcrAB, presented a competitive disadvantage
when compared with HR strain K46.
DISCUSSION
The evolution of antimicrobial resistance in bacteria is driven
by the pressures exerted following exposure to antimicrobials.
However, the impacts of different resistance mechanisms are still
not well understood. We analyzed isolates of different Salmonella
serovars with a broad range of ciprofloxacin MIC distributions
in this study. From studying this curated panel of isolates, the
current study resulted in the following conclusions:
ParC T57S Was Present in Isolates With
Low Ciprofloxacin MICs
The development of FQ resistance is understood to often require
accumulation of multiple mutations in a stepwise process, with
mutations that alter GyrA at codon 83 often being considered
the “first step” to selection of high-level resistance. Here, we
observed a high prevalence of the ParC T57S substitution in
strains with lowest MICs of ciprofloxacin (S and RS strains).
Whether the ParC T57S substitution contributes to quinolone
resistance, is still controversial (Baucheron et al., 2002; Ling
et al., 2003; Eaves et al., 2004; Gunell et al., 2009; Zhang W.H.
et al., 2017). We found that the presence of ParC T57S was
altered as the ciprofloxacin MIC increased; this mutation only
appeared alone in strains with MICCIP ≤ 0.06 mg/L. Therefore,
we suggest that any impact of this mutation alone of quinolone
susceptibility must be low and can only provide a low degree
of protection against ciprofloxacin. This change alone may carry
little fitness cost which would explain its prevalence in the S and
RS strains, however, it may incur a different impact on fitness
when associated with GyrA substitutions as no strain carried a
single substitution within ParC and any GyrA change in any of
the groups. Most resistant strains did carry multiple substitutions
within both GyrA and ParC and the specific nature of these
changes is likely to impact fitness.
In the intermediate isolates where the MICCIP was higher (I;
4–8 mg/L), strains carried a QRDR mutation, such as S83Y or
D87Y/N but the ParC T57S mutation was not present (suggesting
this is not a precursor required for development of resistance).
ParC T57S was seen in R and HR strains, along with multiple
substitutions in both GyrA and ParC, this demonstrates the ParC
T57S substitution is viable when in combination with multiple
other topoisomerase mutations.
Expression of acrAB-tolC was elevated in strains carrying
the ParC T57S substitution, but only those where the MICCIP
was below the resistance breakpoint. This again suggests that
a combination of the ParC T57S change with increased active
efflux activity may be important in the early stages of resistance
development (where MICs are relatively low). The growth
competition assays revealed that the ParC T57S mutation was
associated with enhanced bacterial fitness again supporting a
low-impact but high-fitness role for this substitution.
PMQR Genes Were Associated With
Ciprofloxacin Resistance Development
Plasmid-mediated quinolone resistance determinants cause
decreased susceptibility to FQs while also facilitating the selection
of higher levels of FQ resistance (Rodriguez-Martinez et al.,
2016). In the present study, oqxAB was the most prevalent
PMQR gene detected. It was not present in S strains but was
first observed in RS strains with an MICCIP 0.06 mg/L and
the gene was chromosomally located in all the positive RS
strains. The occurrence of oqxAB in combination with existing
mechanisms, such as ParC T57S and elevated expression of
acrAB-tolC, were linked to significant increases in MICCIP,
compared to strains without oqxAB but with these other changes.
The chromosomal location of oqxAB did not appear to incur a
fitness cost in strains which also increased acrAB-tolC expression
and may represent a successful combination of these two
mechanisms in terms of susceptibility and fitness. Isolates with an
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FIGURE 3 | In vitro bacterial competition assays. Competition coefficient values were obtained from each independent experiment as indicated. Broken horizontal
line, competition coefficient of 1; mean values, short continuous horizontal lines. –, not detected; C+, chromosomally located; P+, plasmid located.
MICCIP of 0.25–0.5 mg/L, also carried mutations in gyrA, which
imposed a fitness cost.
Some isolates where the MICCIP achieved clinical resistance
levels (although without additional mutations in the target
genes) carried >2 PMQR genes (oqxAB, aac(6′)-Ib-cr, and qnrS)
combined with mutation in gyrA. These genes were found in
plasmid locations in intermediate strains (MICCIP 1–2 mg/L)
while being observed at chromosomal locations in R strains
(MICCIP 4–8 mg/L). Interestingly, the R group did not exhibit any
known chromosomal mechanisms, such as target gene mutations
or overexpression of acrAB-tolC for increased resistance, but did
carry three plasmid-borne PMQR genes. This phenomenon is
consistent with previous observations where the presence of 2–3
PMQR genes was observed in ciprofloxacin resistant Salmonella
isolates from pork samples that lacked any target gene mutations
(Lin et al., 2015). Our results confirmed that the presence of
multiple PMQR genes or multiple copies of PMQR genes can
confer resistance to ciprofloxacin.
The Switch of PMQR Gene Location
Between Chromosome and Plasmid
Mediated by IS26-oqxAB Correlated With
Fitness and Stable Development of
Resistance
OqxAB is an efflux pump from the RND family that mediates
resistance to olaquindox, chloramphenicol and nalidixic acid.
The presence of this pump elevates MICs for other antimicrobial
reagents including ampicillin and gentamicin (Hansen et al.,
2007). The pump is encoded by an operon (oqxABR) flanked by
IS26 sequences, constituting a composite transposon (Tn6010)
(Norman et al., 2008).
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FIGURE 4 | Quinolone resistance genes associated with different ciprofloxacin MICs amongst isolates.
The oqxABR operon can form a circular structure to facilitate
mobilization (He et al., 2015). In this study, we observed that
oqxABR shifted from chromosomal to plasmid locations in
isolates with relatively high MICCIP. We performed inverse PCR
to determine whether an IS26-oqxAB circular intermediate was
involved in this process. We found that all 16 oqxAB-positive
strains possessed the circular intermediate regardless of genomic
location. This indicated that the circular intermediate promotes
mobilization of this PMQR between chromosome and plasmid.
Interestingly, we detected qnrS in R strains located on the
chromosome with aac(6′)-Ib-cr and oqxAB. This is consistent
with other several studies, where qnrS co-existing with aac(6′)-
Ib-cr and oqxAB were frequently detected in Salmonella spp. of
food animal origin in China (Zhang et al., 2016; Wang et al.,
2017; Kuang et al., 2018), and qnrS were also detected on the
chromosome along with other PMQR genes (Lin et al., 2015). Co-
existence of qnrS in the chromosome with other genes may be a
strategy that confers a relatively high degree of tolerance to FQs
without a prohibitive fitness cost which may explain the frequent
observation of this combination.
The switch from plasmid to chromosomal location might
represent a bacterial strategy for maintaining a resistance trait
while adapting to antimicrobial stress (Machuca et al., 2014).
Our growth competition assays confirmed that strains carrying
PMQR genes on the chromosome had a growth advantage and
could outcompete strains possessing PMQR genes on a plasmid.
Interestingly, in the majority of our HR strains, only aac(6′)-
Ib-cr was present. The latter gene was located on a plasmid
and its presence coincided with multiple target gene mutations
and overexpression of acrAB. aac(6′)-Ib-cr was associated with a
fitness cost, in consistent with Machuca et al. (2014) observation
in E. coli. Growth competition assays demonstrated that transfer
of the aac(6′)-Ib-cr gene back to a plasmid location resulted in a
fitness cost. Whole genome sequencing data identified a broad
host range plasmid IncQ1 carrying no resistance genes in this
HR strain. Thus, it is likely that the presence of this plasmid
played a role in aac(6′)-Ib-cr gene movement from chromosome
to plasmid, which has been previously suggested (Loftie-Eaton
and Rawlings, 2012; Barry et al., 2019; Chen et al., 2019).
Increased Expression of acrAB-tolC
Plays a Role in Isolates With Low
Ciprofloxacin MICs via marA Rather
Than ramA
Increased drug efflux primarily occurs via overexpression of
AcrAB-TolC, the primary efflux pump, in Enterobacteriaceae and
drug efflux is a primary mechanism for quinolone resistance
in Salmonella (Baucheron et al., 2004; Blair et al., 2009, 2014).
In accordance with studies that analyzed experimentally derived
ciprofloxacin mutants (Redgrave et al., 2014; Hooper and Jacoby,
2015), we observed elevated expression of AcrAB in the early
stages of resistance development prior to the occurrence of gyrA
mutations (Vidovic et al., 2019). Significant levels of acrAB-tolC
were observed in the RS strains.
Multidrug efflux pumps are expressed under precise
transcriptional control. In Salmonella, RamA is often considered
the master regulator of acrAB (Ricci et al., 2014). We did not
detect the overexpression of ramA in strains that expressed
high levels of acrAB but had relatively low ciprofloxacin
MICs (Groups S and RS). Instead, this overexpression was
accompanied by increases in the expression of marA. A similar
observation was made with laboratory selected ciprofloxacin-
resistant mutants where mutation of ramR was mainly seen in
mutants with very high ciprofloxacin MICs (Vidovic et al., 2019).
Interestingly, efflux pump genes were not expressed more in R
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strains compared with S. Typhimurium SL1344, in agreement
with earlier observations made with MDR Klebsiella and MDR
E. coli that strains capable of evolving multiple energetically
favorable QRDR mutations will use less efflux than isolates with
fewer favorable QRDR alterations (Toth et al., 2014; Johnson
et al., 2015). The overexpression of ramA was only detected
in highly resistant strains. Our data suggests that whilst both
MarA and RamA can up-regulate acrAB, there is a preference
for utilizing MarA in less resistant strains and RamA in the
most resistant strains. Both MarA and RamA are pleiotropic
regulators and the overexpression of ramA may play additional
roles as well as regulating acrAB in highly resistant strains more
compatible with this phenotype than over-expression of marA.
This is in line with the previous research in which a deletion in
the RamR-binding sites in the ramA promoter correlated with
highest expression levels of efflux pumps (Fabrega et al., 2016).
In conclusion, we observed a complex interplay between a
pool of quinolone resistance mechanisms, their contribution to
susceptibility and fitness costs (Figure 4). In general, we found no
significant differences between different serovars of Salmonella
suggesting common impacts from these genotypes across the
genus although only S. Indiana isolates were found in the HR
group suggesting they may be more able to develop high level
resistance. Whilst natural variations in genes related to phylogeny
may mask impacts on resistance, the topoisomerase genes and
other known quinolone associated resistance pathways are highly
conserved across the Salmonella genus and studying a large
and diverse panel of real-world isolates can be informative for
mutations circulating in practice which have been selected in
real conditions.
We suggest an important role for substitutions within ParC
and acrAB expression in the early stages of ciprofloxacin
resistance development prior to the occurrence of gyrA
mutations. Highly resistant isolates acquire multiple target site
mutations and PMQR determinants although these are often
integrated in the chromosome to minimize fitness costs and
expression of acrAB-tolC is returned to wild-type levels, probably
for the same reason. Whilst we are able here to identify
genotypes which appear to be fit in conferring different levels of
ciprofloxacin tolerance, it is still not possible to precisely assign
a universal pathway in relation to the selection of resistance.
Understanding the relative fitness of different genotypes in
different selective conditions will help predict the evolutionary
trajectory of AMR while also helping us to understand how
resistance emerges in complex situations where multiple genes
collaborate to confer resistance.
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